Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
Bearz
Alessandra
A
Fratino
Lucia
L
Spazzapan
Simon
S
Berretta
Massimiliano
M
Giacalone
Annalisa
A
Simonelli
Cecilia
C
Tirelli
Umberto
U
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib